Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Drugs in Context
|
May 11, 2023
Non-small-cell lung cancer: how to manage <i>BRAF</i>-mutated disease
Giorgia Guaitoli, Lodovica Zullo, Marcello Tiseo, et al.
Frontiers in Oncology
|
October 11, 2021
Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors?
Enrica Teresa Tanda, Elena Croce, Francesco Spagnolo, et al.
BMC Pulmonary Medicine
|
January 8, 2022
Potential application of cryobiopsy for histo-molecular characterization of mediastinal lymph nodes in patients with thoracic malignancies: a case presentation series and implications for future developments
Carlo Genova, Elena Tagliabue, Marco Mora, et al.
Expert Review of Respiratory Medicine
|
January 10, 2020
Targeted therapy of oncogenic-driven advanced non-small cell lung cancer: recent advances and new perspectives
Carlo Genova, Giovanni Rossi, Marco Tagliamento, et al.
Nature Reviews. Disease Primers
|
August 21, 2025
Lung metastases
Lodovica Zullo, Dimitris Filippiadis, Lizza E L Hendriks, et al.
JCO Precision Oncology
|
August 1, 2024
Disease Course and Treatment Outcomes in Patients With De Novo Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 20 Insertion: Two Case Reports
Lodovica Zullo, Elora Castanet, Zineb Maaradji, et al.
International Journal of Molecular Sciences
|
January 11, 2024
Molecular and Genetic Advances in Small Cell Lung Cancer Landscape: From Homogeneity to Diversity
Lodovica Zullo, Filippo Gustavo Dall'Olio, Giovanni Rossi, et al.
Cancers
|
August 29, 2024
Early-Stage Non-Small Cell Lung Cancer: New Challenges with Immune Checkpoint Blockers and Targeted Therapies
Pernelle Lavaud, Martina Bortolot, Lodovica Zullo, et al.
Cancers
|
January 21, 2022
Exploring Response to Immunotherapy in Non-Small Cell Lung Cancer Using Delta-Radiomics
Emanuele Barabino, Giovanni Rossi, Silvia Pamparino, et al.
JCO Precision Oncology
|
April 16, 2025
<i>BRAF</i> Kinase Domain Duplication as a Potential On-Target Resistance Mechanism After Dabrafenib-Trametinib Therapy in a Patient With <i>BRAF</i><sup>V600E</sup>-Mutated Lung Adenocarcinoma
Pierre de Priester, Lodovica Zullo, Damien Vasseur, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Drugs in Context
|
May 11, 2023
Non-small-cell lung cancer: how to manage <i>BRAF</i>-mutated disease
Giorgia Guaitoli, Lodovica Zullo, Marcello Tiseo, et al.
Frontiers in Oncology
|
October 11, 2021
Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors?
Enrica Teresa Tanda, Elena Croce, Francesco Spagnolo, et al.
BMC Pulmonary Medicine
|
January 8, 2022
Potential application of cryobiopsy for histo-molecular characterization of mediastinal lymph nodes in patients with thoracic malignancies: a case presentation series and implications for future developments
Carlo Genova, Elena Tagliabue, Marco Mora, et al.
Expert Review of Respiratory Medicine
|
January 10, 2020
Targeted therapy of oncogenic-driven advanced non-small cell lung cancer: recent advances and new perspectives
Carlo Genova, Giovanni Rossi, Marco Tagliamento, et al.
Nature Reviews. Disease Primers
|
August 21, 2025
Lung metastases
Lodovica Zullo, Dimitris Filippiadis, Lizza E L Hendriks, et al.
JCO Precision Oncology
|
August 1, 2024
Disease Course and Treatment Outcomes in Patients With De Novo Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 20 Insertion: Two Case Reports
Lodovica Zullo, Elora Castanet, Zineb Maaradji, et al.
International Journal of Molecular Sciences
|
January 11, 2024
Molecular and Genetic Advances in Small Cell Lung Cancer Landscape: From Homogeneity to Diversity
Lodovica Zullo, Filippo Gustavo Dall'Olio, Giovanni Rossi, et al.
Cancers
|
August 29, 2024
Early-Stage Non-Small Cell Lung Cancer: New Challenges with Immune Checkpoint Blockers and Targeted Therapies
Pernelle Lavaud, Martina Bortolot, Lodovica Zullo, et al.
Cancers
|
January 21, 2022
Exploring Response to Immunotherapy in Non-Small Cell Lung Cancer Using Delta-Radiomics
Emanuele Barabino, Giovanni Rossi, Silvia Pamparino, et al.
JCO Precision Oncology
|
April 16, 2025
<i>BRAF</i> Kinase Domain Duplication as a Potential On-Target Resistance Mechanism After Dabrafenib-Trametinib Therapy in a Patient With <i>BRAF</i><sup>V600E</sup>-Mutated Lung Adenocarcinoma
Pierre de Priester, Lodovica Zullo, Damien Vasseur, et al.
Page
of 3